Development and testing of the insulin treatment experience questionnaire (ITEQ)

Patient

Volumn 3, Issue 1, 2010, Pages 45-58

  Moock, Jrn ^a   Hessel, Franz ^b   Ziegeler, Diana ^a   Kubiak, Thomas ^a   Kohlmann, Thomas ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ARTICLE; DIABETES CONTROL; HUMAN; INSULIN TREATMENT; LEISURE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT SATISFACTION; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; PSYCHOMETRY; QUESTIONNAIRE; SLEEP; WEIGHT CONTROL;

EID: 77953429270     PISSN: 11781653     EISSN: 11781661     Source Type: Journal    
DOI: 10.2165/11319510-000000000-00000     Document Type: Article

References (34)

1. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27 (5): 1047-1053
2. Massi-Benedetti M. The cost of diabetes type II in Europe: the CODE-2 study. Diabetologica 2002; 45: S1-4
3. Turner RC, Millns H, Neil HAW, et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). BMJ 1998; 316 (7134): 823-828
4. Hogan P, Dall T, Nikolov P. Economic costs of diabetes in the US in 2002. Diabetes Care 2003; 26: 917-932
5. American Diabetes Association. Economic costs of diabetes in the US in 2007. Diabetes Care 2008; 31 (3): 596-615
6. Rubin RR, Peyrot M. Quality of life and diabetes. Diabetes Metab Res 1999; 15: 205-218
7. Watkins K, Connell CM. Measurement of health-related QOL in diabetes mellitus. Pharmacoeconomics 2004; 22 (17): 1109-1126
8. Rose M, Burkert U, Scholler G, et al. Determinants of quality of life of patients with diabetes under intensified insulin therapy. Diabetes Care 1998; 21: 1876-1883
9. Bradley C. The Diabetes Treatment Satisfaction Questionnaire: DTSQ. In: Bradley C, editor. Handbook of psychology and diabetes: a guide to psychological measurement in diabetes research and practice. Amsterdam: Harwood Academic Publishers, 1994: 111-132
10. Anderson RT, Skovlund SE,Marrero D, et al. Development and validation of the insulin treatment satisfaction questionnaire. Clin Ther 2004; 26 (4): 565-578
11. Hermanns N, Kulzer B, Krichbaum M, et al. How to screen for depression and emotional problems in patients with diabetes: comparison of screening characteristics of depression questionnaires, measurement of diabetes-specific emotional problems and standard clinical assessment. Diabetologia 2006; 49: 469-477
12. FDA. Draft guidance for industry on patient-reported outcome measures: use in medicinal product development to support labelling claims. Fed Register 2006; 71: 5862-5863
13. Committee for Medicinal Products for Human Use. Reflection paper on the regulatory guidance for the use of health-related quality of life (HRQL) measures in the evaluation of medicinal products. 2005 Jul 25 [online]. Available from URL: http://www.emea.europa.eu/pdfs/human/ ewp/-13939104en.pdf [Accessed 2009 Feb 11]
14. Quinn Patton M. Qualitative research and evaluation methods. 3rd ed. Thousand Oaks (CA): Sage Publications, 2002
15. Neumann WL. Basics of social research: qualitative and quantitative approaches. Boston (MA): Pearson, 2007
16. Kitzinger J. Introducing focus groups. BMJ 1995; 311: 299-302
17. Silverman D. Doing qualitative research: a practical handbook. Newbury Park (CA): Sage, 2000
18. Harb B, Kubiak T, Roth R. Der Diabetes Treatment Satisfaction Questionnaire. In: Bengel JC, Wirtz M, Zwingmann C, editors. Diagnostische Verfahren in der Rehabilitation: Verfahren zum krankheitsü bergreifenden Einsatz und fü r ausgewä hlte Indikationsgebiete. Göttingen: Hogrefe, 2008: 266-269
19. Polonsky WH, Anderson BJ, Lohrer PA, et al. Assessment of diabetes-related distress. Diabetes Care 1995; 18 (6): 754-760
20. Kubiak T, Hermanns N, Kulzer B. Der Problem Areas in Diabetes (PAID) Fragebogen. In: Bengel J, Wirtz M, Zwingmann C, editors. Diagnostische Verfahren in der Rehabilitation-Verfahren zum krankheitsü bergreifenden Einsatz und fü r ausgewä hlte Indikationsgebiete. Göttingen: Hogrefe, 2008: 276-279
21. Streiner DL, Norman GR. Health measurement scales: a practical guide to their development and use. 3rd ed. Oxford: Oxford University Press, 2003
22. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951; 16: 297-334
23. Nunnally JC, Bernstein IH. Psychometric theory. 3rd ed. New York: McGraw-Hill Inc, 1994
24. Hays RD, Hayashi T. Beyond internal consistency reliability: rationale and user's guide for Multitrait analysis program on the microcomputer. Behav Res Methods Instrum Comput 1990; 22: 167-175
25. Fayers PM, Machin D. Quality of life: the assessment analysis and interpretation of patient reported outcomes. 2nd ed. Chichester: John Wiley & Sons, 2007
26. Campbell DT, Fiske DW. Convergent and discriminate validation by multitrait-multimethod matrix. Psychol Bull 1959; 56 (2): 81-105
27. Howard KI, Forehand GC. A method for correcting itemtotal correlations for the effect of relevant item inclusion. Educat Psychol Measures 1962; 22: 731
28. Juniper EF, Gordon HG, Roman J. How to develop and validate a new health-related quality of life instrument. In: Spilker B, editor. Quality of life and pharmacoeconomics in clinical trials. 2nd ed. Philadelphia (PA): Lippincott- Raven Publishers, 1996: 49-56
29. Cappelleri JC, Gerber RA, Kourides IA, et al. Development and factor analysis of a questionnaire to measure patient satisfaction with injected and inhaled insulin for type 1 diabetes. Diabetes Care 2000; 23 (12): 1799-1803
30. Brod M, Christensen T, Bushnell D. Maximizing the value of validation findings to better understand treatment satisfaction issues for diabetes. Qual Life Res 2007; 16: 1053-1063
31. Brod M, Cobden D, Lammert M, et al. Examining correlates of treatment satisfaction for injectable insulin in type 2 diabetes: lessons learned from a clinical trial comparing biphasic and basal analogues. Health Qual Life Outcomes 2007; 5: 8
32. Brod M, Skovlund SE, Wittrup-Jensen KU. Measuring the impact of diabetes through patient report of treatment satisfaction, productivity and symptom experience. Qual Life Res 2006; 15 (3): 481-491
33. Atkinson MJ, Sinha A, Hass SL, et al. Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health Qual Life Outcomes 2004; 2: 12
34. Revicki DA, Osoba D, Fairclough D, et al. Recommendations on health-related quality of life research to support labeling and promotional claims in the United States. Qual Life Res 2000; 9: 887-900